1 / 16

Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in  Cells

Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in  Cells. Mario E. Moreno . INTRODUCTION. Type I Diabetes, or insulin-dependent diabetes mellitus, is caused by T cell-mediated autoimmunce destruction of pancreatic  cells.

ulmer
Download Presentation

Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in  Cells

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in  Cells Mario E. Moreno

  2. INTRODUCTION • Type I Diabetes, or insulin-dependent diabetes mellitus, is caused by T cell-mediated autoimmunce destruction of pancreatic  cells. • Glutamic acid decarboxylase (GAD) is the strongest  cell autoantigen that triggers the earliest T cell proliferative response. • Does suppression of GAD in  cells of diabetes prone non-obese diabetic (NOD) mice inhibit diabetes?

  3. Suppression of  Cell GAD Expression

  4. Fig. 1A: RIP-antisense GAD65.67 transgene structure • Transgenic mice contain the antisense GAD transgene for both isoforms of rat GAD cDNA (rGAD65 and rGAD67) under the control of the rat insulin promoter (RIP). • Fig. 1B: Expression of antisense GAD transcript by reverse transcriptase PCR • Six line of antisense GAD65.67 transgenic NOD mice were established and designated as H-AS-GAD-NOD, M-AS-GAD-NOD, L-AS-GAD-NOD, H-AS-GAD-NOD, M-AS-GAD-NOD, L-AS-GAD-NOD.

  5. Fig. 1C: Pedigree of AS-GAD transgenic mice • Eleven positive founder mice were obtained. • Six mice were selected based on antisense transcript expression and backcrossed with NOD mice. • Fig. 1D: Norther blot analysis • Northern blot of antisense GAD transcripts in the first three different lines of transgenic NOD mice (H-, M-, and L-AS-GAD-NOD) and transgenic-negative littermates.

  6. Fig. 1E: Western Blot Analysis • Suppression of GAD expression in pancreatic islets and brain tissue in the first three different lines of transgenic NOD mice (H-, M-, and L-AS-GAD-NOD) and transgenic-negative littermates. • Fig. 1F: Immunohistochemical Staining • Staining of pancreatic islets with antibodies to GAD and insulin from 10 week old H-, M-, and L-AS-GAD-NOD and transgenic-negative littermates.

  7. Suppression of GAD Expression on the Development of Diabetes

  8. Fig. 2A and 2C: Incidence of Diabetes • Incidence of diabetes was determined by positive glycosuria and confirmed by hyperglycemia. • Non of the L-AS-GAD-NOD mice developed diabetes. • GAD expression is necessary for the development of diabetes. • Fig. 2B and 2D: Histological Examination of Insulitis • Grade 0: normal islets; grade 1: less than 25% mononuclear infiltration; grade 2: 25-50% mononuclear infiltration; grade 3: over 50% mononuclear infiltration, grade 4: small retracted islets with few mononuclear cells.

  9. Fig. 2E-2H: Photomicrographs of pancreatic islet and salivary gland sections • Autoimmunity was not affected in other tissues

  10. The effect of  cell-specific suppression of GAD expression on the development of  cell-cytotoxic T cells and T cell immune responses to islet autoantigens

  11. Fig. 3A: Incidence of diabetes in NOD scid mice that received splenocytes isolated from H-AS-GAD-NOD mice. • The generation of T cells capable of adoptively transferring diabetes is blocked in the absence of GAD expression in the  cells. • The generation of both diabetogenic CD4+ and CD8+ T cells was blocked in the absence of GAD expressio in the  cells

  12. Fig. 3B-D: Splenic T cell proliferative response to islet antigens. Splenocytes isolated from 8-week-old (B), 12-week-old (C), 15-week-old (D). • Intravenous or intrathymic immunization of NOD mice with GAD suppresses T cell responses to GAD, heat shock protein (HSP) 60, carboxypeptidase H, and peripherin. •  cell specific suppression of GAD gene expression diminishes the T Cell immune response to other  cell autoantigens as well as GAD.

  13. Protection of GAD-suppressed  cells from autoimmune attack by diabetogenic T cells

  14. Fig. 4A: Prevention of the recurrence of diabetes by the transplantation of GAD-suppressed islets. • All recipients showed a recurrence of diabetes. • Fig. 4B:Insulitis grade in islet grafts. • Grade description provided in fig. 2B • Fig. 4C: Photomicrographs of representative islet grafts. • H-AS-GAD-NOD mice show intact islets • Transgene-negative mice show massive infiltration of islets by mononuclear cells.

  15. Fig. 4D: Adoptive transfer of diabetes to by acutely diabetic splenocytes. • GAD expression is required for autoimmune destruction of  cells.

  16. Conclusion •  cell-specific suppression of GAD expression is sufficient to nearly completely prevent autoimmune diabetes in NOD mice, in association with the suppression of GAD-reactive T cells. • GAD expression is essential for the induction of diabetogenic T cells • Diabetogenic T cells cannot provoke diabetes in NOD mice in the absence of GAD from  cells.

More Related